… and Accredited Partner Status. World Patent Ratings provides research reports, … ImmuCell Corp, AVAX Technologies Inc, Affymax Inc, Anterios Inc, Manhattan Scientifics … .com. Contact World Patent Ratings: World Patent Ratings 1680 Meridian Avenue …

… biopharmaceutical companies Myrexis, Inc. and Affymax, Inc. Mr. Pearce commented, “I … potential inability to maintain sufficient patent protection for our technology and …

… FibroGen, Johnson & Johnson, Affymax, Chugai Pharmaceutical, Hoffmann-La Roche … collaborations, acquisitions, mergers, licensing patent details, and other information for … Johnson & Johnson peginesatide: Affymax epoetin beta: Chugai Pharmaceutical r …

… for treatment-resistant cancers and Affymax focused on the development of … as a significant IP/patent portfolio in the use of …

… development and drug discovery, at Affymax Research Institute through its acquisition … Glaxo Wellcome, plc. Prior to Affymax, he was at Anergen and … Genesys). Dr. Capon also holds patents on the XenoMouse for the …

… drug products.  He has nine patents for his development work, including … held senior scientific roles at Affymax, Rigel and 3M. ABOUT TURN …

… to the filing of numerous patent applications. He also played a … ultimately acquired by Pfizer) and Affymax/Glaxo-Wellcome, where he … over 70 scientific papers and patents. About Goldfinch Bio Goldfinch Bio …

… Vice President of Research at Affymax Research Institute, where he pioneered … on more than 50 issued patents in the U.S. He …

… Galenica AG, Anthera Pharmaceuticals, Affymax, Omeros Corporation and Cyclacel Pharmaceuticals … Other risks include uncertainty of patent protection and proprietary rights, … whether patent applications and issued patents will offer adequate …